EirGenix (6589.TWO) Stock Price

EirGenix Price

CLOSED
46.05TWD+0.65 (+1.42 %)
Market closed

Revenue has compounded at 48.7% per year over the past 12 years to 1.01 B TWD. EirGenix's net margin stands at -75.7%, down from -2.5% several years earlier. The stock trades about 14% above its 52-week low.

EirGenix stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of EirGenix over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how EirGenix stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing EirGenix's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

EirGenix Stock Price History
DateEirGenix Price
8/3/202646.05 TWD
7/31/202645.40 TWD
7/30/202645.05 TWD
7/29/202645.80 TWD
7/28/202645.95 TWD
7/27/202647.05 TWD
7/24/202645.60 TWD
7/23/202645.60 TWD
7/22/202646.60 TWD
7/21/202645.50 TWD
7/20/202644.80 TWD
7/17/202644.85 TWD
7/16/202646.25 TWD
7/15/202647.30 TWD
7/14/202646.60 TWD
7/13/202649.30 TWD
7/10/202648.25 TWD
7/9/202648.25 TWD
7/8/202649.40 TWD
7/7/202650.70 TWD
7/6/202651.40 TWD
7/3/202649.70 TWD
7/2/202646.90 TWD
7/1/202648.50 TWD
6/30/202649.90 TWD
6/29/202648.40 TWD
6/26/202646.10 TWD
6/25/202646.70 TWD
6/24/202647.10 TWD
6/23/202646.55 TWD
6/22/202646.65 TWD
6/18/202645.65 TWD
6/17/202645.60 TWD
6/16/202644.60 TWD
6/15/202644.90 TWD
6/12/202644.95 TWD
6/11/202644.65 TWD
6/10/202645.50 TWD
6/9/202645.00 TWD
6/8/202643.15 TWD
6/5/202644.70 TWD
6/4/202645.85 TWD
6/3/202644.30 TWD
6/2/202643.15 TWD
6/1/202643.70 TWD
5/29/202641.50 TWD
5/28/202641.45 TWD
5/27/202640.50 TWD
5/26/202641.00 TWD
5/25/202642.00 TWD
5/22/202643.25 TWD
5/21/202643.65 TWD
5/20/202643.55 TWD
5/19/202643.90 TWD
5/18/202644.40 TWD
5/15/202644.60 TWD
5/14/202640.55 TWD
5/13/202641.35 TWD
5/12/202643.60 TWD
5/11/202645.10 TWD
5/8/202645.35 TWD
5/7/202646.10 TWD
5/6/202645.55 TWD
5/5/202646.05 TWD
5/4/202645.70 TWD
4/30/202645.15 TWD
4/29/202647.10 TWD
4/28/202647.65 TWD
4/27/202646.10 TWD
4/24/202645.60 TWD
4/23/202647.00 TWD
4/22/202648.85 TWD
4/21/202648.35 TWD
4/20/202649.00 TWD
4/17/202650.60 TWD
4/16/202651.30 TWD
4/15/202651.50 TWD
4/14/202651.30 TWD
4/13/202652.00 TWD
4/10/202652.90 TWD
4/9/202654.40 TWD
4/8/202655.80 TWD
4/7/202655.80 TWD
4/2/202657.30 TWD
4/1/202657.00 TWD
3/31/202654.80 TWD
3/30/202655.70 TWD
3/27/202656.90 TWD
3/26/202656.90 TWD
3/25/202658.40 TWD
3/24/202657.20 TWD
3/23/202656.10 TWD
3/20/202656.50 TWD
3/19/202656.80 TWD
3/18/202659.40 TWD
3/17/202657.40 TWD
3/16/202656.90 TWD
3/13/202656.70 TWD
3/12/202657.70 TWD
3/11/202659.10 TWD
3/10/202657.90 TWD
3/9/202657.00 TWD
3/6/202659.80 TWD
3/5/202661.00 TWD
3/4/202658.80 TWD
3/3/202660.40 TWD
3/2/202661.20 TWD
2/26/202660.60 TWD
2/25/202661.00 TWD
2/24/202661.50 TWD
2/23/202661.30 TWD
2/11/202661.20 TWD
2/10/202661.00 TWD
2/9/202659.90 TWD
2/6/202660.40 TWD
2/5/202662.10 TWD
2/4/202661.80 TWD
2/3/202660.30 TWD
2/2/202660.40 TWD
1/30/202662.20 TWD
1/29/202663.30 TWD
1/28/202663.80 TWD
1/27/202665.30 TWD
1/26/202664.30 TWD
1/23/202664.70 TWD
1/22/202662.80 TWD
1/21/202663.00 TWD
1/20/202664.10 TWD
1/19/202665.20 TWD
1/16/202665.80 TWD
1/15/202667.00 TWD
1/14/202666.00 TWD
1/13/202664.60 TWD
1/12/202663.70 TWD
1/9/202663.10 TWD
1/8/202663.40 TWD
1/7/202662.40 TWD
1/6/202661.80 TWD
1/5/202661.50 TWD
1/2/202662.10 TWD
12/31/202561.70 TWD
12/30/202561.70 TWD
12/29/202562.30 TWD
12/26/202562.40 TWD
12/24/202562.60 TWD
12/23/202562.90 TWD
12/22/202563.40 TWD
12/19/202563.50 TWD
12/18/202563.20 TWD
12/17/202563.10 TWD
12/16/202564.20 TWD
12/15/202565.60 TWD
12/12/202567.20 TWD
12/11/202574.60 TWD
12/10/202574.50 TWD
12/9/202575.50 TWD
12/8/202575.10 TWD
12/5/202575.30 TWD
12/4/202575.60 TWD
12/3/202573.90 TWD
12/2/202575.20 TWD
12/1/202574.40 TWD
11/28/202574.50 TWD
11/27/202573.80 TWD
11/26/202575.60 TWD
11/25/202573.70 TWD
11/24/202572.40 TWD
11/21/202572.30 TWD
11/20/202572.40 TWD
11/19/202572.80 TWD
11/18/202574.60 TWD
11/17/202576.50 TWD
11/14/202581.90 TWD
11/13/202574.50 TWD
11/12/202567.80 TWD
11/11/202566.60 TWD
11/10/202565.00 TWD
11/7/202567.20 TWD
11/6/202569.20 TWD
11/5/202569.40 TWD
11/4/202566.30 TWD
11/3/202566.30 TWD
10/31/202567.00 TWD
10/30/202565.80 TWD
10/29/202566.10 TWD
10/28/202567.10 TWD
10/27/202567.50 TWD
10/23/202569.10 TWD
10/22/202570.20 TWD
10/21/202569.70 TWD
10/20/202568.50 TWD
10/17/202570.30 TWD
10/16/202570.20 TWD
10/15/202569.70 TWD
10/14/202574.80 TWD
10/13/202572.40 TWD
10/9/202571.50 TWD
10/8/202572.00 TWD
10/7/202573.00 TWD
10/3/202572.30 TWD
10/2/202574.00 TWD
10/1/202572.80 TWD
9/30/202570.30 TWD
9/26/202566.70 TWD
9/25/202562.90 TWD
9/24/202560.70 TWD
9/23/202560.60 TWD
9/22/202560.50 TWD
9/19/202560.00 TWD
9/18/202560.80 TWD
9/17/202560.50 TWD
9/16/202560.70 TWD
9/15/202560.70 TWD
9/12/202561.00 TWD
9/11/202561.40 TWD
9/10/202562.40 TWD
9/9/202563.50 TWD
9/8/202565.10 TWD
9/5/202563.50 TWD
9/4/202561.60 TWD
9/3/202561.40 TWD
9/2/202560.30 TWD
9/1/202560.20 TWD
8/29/202560.90 TWD
8/28/202561.40 TWD
8/27/202561.50 TWD
8/26/202562.50 TWD
8/25/202561.50 TWD
8/22/202561.60 TWD
8/21/202561.20 TWD
8/20/202560.30 TWD
8/19/202560.50 TWD
8/18/202560.70 TWD
8/15/202561.70 TWD
8/14/202562.90 TWD
8/13/202562.20 TWD
8/12/202561.40 TWD
8/11/202560.90 TWD
8/8/202562.00 TWD
8/7/202561.80 TWD
8/6/202562.50 TWD
8/5/202564.20 TWD
Access this data via the Eulerpool API
Get Free API Key

EirGenix Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
1.07 B TWD
-986.00 M TWD
-1.04 B TWD
Jan 1, 2021
1.70 B TWD
-57.62 M TWD
-42.58 M TWD
Jan 1, 2022
1.48 B TWD
-331.21 M TWD
-115.54 M TWD
Jan 1, 2023
1.02 B TWD
-1.03 B TWD
-915.21 M TWD
Jan 1, 2024
1.01 B TWD
-865.87 M TWD
-698.34 M TWD
Jan 1, 2025
1.01 B TWD
-843.38 M TWD
-760.55 M TWD
Jan 1, 2026 (e)
1.38 B TWD
-675.31 M TWD
-524.29 M TWD
Jan 1, 2027 (e)
2.34 B TWD
-1.15 B TWD
174.76 M TWD

EirGenix Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 4, 2026, 11:25 AM
 
REVENUEB TWD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB TWD
EBITB TWD
EBIT MARGIN%
NET INCOMEB TWD
NET INCOME GROWTH%
SHARESM
20132014201520162017201820192020202120222023202420252026e2027e
0.010.050.100.250.300.280.481.071.701.481.021.011.011.382.34
–562.5092.45148.0417.39-5.0568.79125.0058.45-12.73-30.99-1.37-0.3036.9270.28
-512.50-39.626.8634.3938.7228.0153.3670.0364.4151.0523.0921.6319.2019.2019.20
-0.04-0.020.010.090.120.080.250.751.090.760.240.220.190.260.45
-0.11-0.15-0.16-0.14-0.18-0.38-0.85-0.99-0.06-0.33-1.03-0.87-0.84-0.68-1.15
-1,312.50-290.57-154.90-54.15-58.92-133.33-177.94-92.06-3.36-22.35-100.88-85.81-83.88-49.06-49.04
-0.10-0.13-0.13-0.11-0.17-0.37-0.86-1.04-0.04-0.12-0.92-0.70-0.76-0.520.17
–26.921.52-16.4255.36110.92134.3321.05-95.97173.81695.65-23.728.88-31.05-133.21
42.8060.0088.41108.27114.42136.11175.64205.22300.39304.34305.41306.41306.41306.41306.41
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales EirGenix generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue EirGenix retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare EirGenix's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares EirGenix has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against EirGenix's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

EirGenix stock margins

The EirGenix margin analysis displays the gross margin, EBIT margin, as well as the profit margin of EirGenix. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for EirGenix.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
70.04 %
-91.99 %
-97.19 %
Jan 1, 2021
64.40 %
-3.39 %
-2.51 %
Jan 1, 2022
51.08 %
-22.36 %
-7.80 %
Jan 1, 2023
23.15 %
-100.91 %
-89.49 %
Jan 1, 2024
21.70 %
-85.82 %
-69.21 %
Jan 1, 2025
19.28 %
-83.90 %
-75.67 %
Jan 1, 2026 (e)
19.28 %
-49.04 %
-38.07 %
Jan 1, 2027 (e)
19.28 %
-49.04 %
7.46 %

EirGenix Stock Revenue, EBIT, Earnings per Share

The EirGenix earnings per share therefore indicates how much revenue EirGenix has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
5.22 TWD
-4.80 TWD
-5.08 TWD
Jan 1, 2021
5.65 TWD
-0.19 TWD
-0.14 TWD
Jan 1, 2022
4.87 TWD
-1.09 TWD
-0.38 TWD
Jan 1, 2023
3.35 TWD
-3.38 TWD
-3.00 TWD
Jan 1, 2024
3.29 TWD
-2.83 TWD
-2.28 TWD
Jan 1, 2025
0.00 TWD
0.00 TWD
0.00 TWD
Jan 1, 2026 (e)
4.49 TWD
-2.20 TWD
-1.71 TWD
Jan 1, 2027 (e)
7.64 TWD
-3.75 TWD
0.57 TWD

EirGenix business model & stock analysis

EirGenix Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

EirGenix historical P/E ratio, EBIT multiple, and P/S ratio

EirGenix annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

EirGenix shares outstanding

The number of shares of EirGenix was 306.41 M in 2025. This indicates how many shares EirGenix is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
205.22 M Stocks
Jan 1, 2021
300.39 M Stocks
Jan 1, 2022
304.34 M Stocks
Jan 1, 2023
305.41 M Stocks
Jan 1, 2024
306.41 M Stocks
Jan 1, 2025
306.41 M Stocks
Jan 1, 2026 (e)
306.41 M Stocks
Jan 1, 2027 (e)
306.41 M Stocks
Price targets and forecasts for EirGenix are not yet available.

EirGenix Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
5/8/2024-0.20TWD-454.23 MTWD-2024 Q1
3/8/20240.10TWD-324.45 MTWD-2023 Q4

EirGenix shareholder structure

% Name
8.96934%
Foxconn Technology Co Ltd
Foxconn Technology Co Ltd
8.64318%
Yonglin Capital Holding Co. , Ltd.
Yonglin Capital Holding Co. , Ltd.
6.05121%
Formosa Laboratories, Inc.
Formosa Laboratories, Inc.
4.98663%
National Development Fund, Executive Yuan
National Development Fund, Executive Yuan
4.26549%
Yao Hwa Glass Co Ltd
Yao Hwa Glass Co Ltd
3.58806%
Pan (Wen Ming)
Pan (Wen Ming)

EirGenix Beneficial Ownership Filings (SEC 13D/G)

Free Float
64.8%
Float Shares
-
Shares Outstanding
-

EirGenix Executives and Management Board

15 members · 36 % women

LL

Mr. Lee-Cheng Liu

Chairman of the Board, General Manager, Chief Executive Officer-BioPharma Business Unit · since 2023

37.44 M TWD

Management

CC

Mr. Chih-Jung Chang

Chief Executive Officer-BioManufacturing Business Unit, Senior Deputy General Manager · since 2023

6.73 M TWD
HY

Ms. Hsiu-Chuan Yang

Chief Financial Officer, Deputy General Manager, Corporate Governance Officer

6.12 M TWD
SJ

Mr. Shang-Chung Ju

Chief Engineer

4.98 M TWD
CL

Ms. Ching-Wen Lin

Senior Deputy General Manager, Chief Business Officer

–

Board of Directors

MC

Mr. Ming-Shen Chen

Independent Director

990,000.00 TWD
HC

Ms. Hsiu-Hui Chen

Director

30,000.00 TWD
YC

Ms. Yu-Ting Chen

Director

25,000.00 TWD
CC

Mr. Cheng-Yu Cheng

Director

25,000.00 TWD
CL

Mr. Chun-Fu Lu

Director

25,000.00 TWD
CC

Chiuan-Jeng Chen

Director

–

Frequently asked questions about EirGenix

9 analysts currently rate the EirGenix stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect EirGenix to generate revenue of 1.38 B TWD and earnings per share of -1.71 TWD.

EirGenix Analyst Price Targets 2026

Converted at the current exchange rate, the EirGenix share trades at 1.23 EUR (46.05 TWD).

No history available for EirGenix.

The expected revenue of EirGenix is 1.38 B TWD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of EirGenix is -524.29 M TWD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of EirGenix is currently -26.91. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the EirGenix stock.

The price-to-sales ratio (P/S) of EirGenix is currently 10.25. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the EirGenix stock.

The Eulerpool Quality Score for EirGenix is 3/10.

The ISIN of EirGenix is TW0006589005. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of EirGenix is 6589.TWO. The ticker symbol is used to trade EirGenix shares on the stock exchange.

EirGenix paid dividends every year for the past 0 years.

EirGenix is assigned to the 'Health' sector.

The dividends of EirGenix are distributed in TWD.

All fundamentals and in-depth analysis of EirGenix

Our stock analysis for EirGenix stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of EirGenix. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

EirGenix Stock
EirGenix Revenue→
EirGenix Stock
EirGenix Net Income→
EirGenix Stock
EirGenix P/E→
EirGenix Stock
EirGenix P/S→
EirGenix Stock
EirGenix EBIT→
EirGenix Stock
EirGenix Dividend→
EirGenix Stock
EirGenix Directors Dealings→
EirGenix Stock
EirGenix Stocks→
EirGenix Stock
EirGenix Market capitalization→
EirGenix Stock
EirGenix Debt→
EirGenix Stock
EirGenix Liabilities→
EirGenix Stock
EirGenix Equity→
EirGenix Stock
EirGenix AAQS→
EirGenix Stock
EirGenix Employees→
EirGenix Stock
EirGenix ROE→
EirGenix Stock
EirGenix ROA→
EirGenix Stock
EirGenix ROCE→
EirGenix Stock
EirGenix News→
EirGenix Stock
EirGenix Analyst Price Targets→

Health Stocks

Eisai CoEiken Chemical CoEkachai Medical Care PCLEgyptian International Pharmaceutical Industries Company SAEEKF Diagnostics HoldingsEgetis Therapeutics AB (publ)EkocorpeFFECTOR TherapeuticsEkso Bionics HoldingsEDX Medical GroupEl En SpAEdwards LifesciencesAll Stocks A–Z →